What's breaking now, across thousands of outlets.
Thyme Care has raised $125 million from investors in a deal doubling the cancer startup's valuation as it tackles critical disease treatment gaps.
We haven't written up this one. CNBC has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
Key PointsThe transaction involved 20,000 shares with a total value of ~$1.1 million at the weighted-average execution price.
In this week's Crypto Long & Short, Varun Datta of Truth Ventures writes that crypto venture capital's retreat to later-stage deals is a consensus trade dressed as discipline.
Key PointsThe stock sale was valued at $287,000.
The cloud-native database specialist failed to reassure skittish investors.
Transaction Expands Product Offering and Geographic Reach Across the Mid-South and Central United States ROSEMONT, Ill. — Trimlite, a value-added distributor of residential doors and door products and…
A sports journalist, a historian and a filmmaker join students from Qatar, Canada and Mexico to debate the impact of wealthy club backing on football and its fans DOHA, Qatar — Football fans embody…
